Immunity to, and consequences of, Mucosa-associated fungi

I.D. Iliev (New York City, United States of America)

Source: ERS Research Seminar 2016
Number: 3

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I.D. Iliev (New York City, United States of America). Immunity to, and consequences of, Mucosa-associated fungi. ERS Research Seminar 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Allergy and immunity to fungal infections and colonization
Source: Eur Respir J 2002; 19: 151-157
Year: 2002



Cytotoxic responses of mucosal-associated Invariant T cells to NTHi infection
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016

Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Source: Eur Respir J 2004; 23: 327-333
Year: 2004



The ancient rubredoxin system: An efficient defense mechanism of pseudomonas aeruginosa during infections
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014

Common organisms causing community acquired pneumonia
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Pathogen profile of lung infections in systemic autoimmune diseases
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Mapping the cellular source and role of IL-22 in murine lung infections
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015

An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015


A human lung explant model for the study of antiviral drugs
Source: Annual Congress 2013 –Interesting research questions
Year: 2013


Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Epidemiology and biology of the common respiratory viruses, atypical bacteria, and bacteria
Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation
Year: 2004

Broad spectrum of virulence of pseudomonas aeruginosa clones characterized in a murine airway infection model
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Regulation of dectin-1 in cystic fibrosis bronchial epithelial cells during host pathogen interactions
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016

Microbiome effects on immunity, health and diseases of the lungs
Source: Virtual Congress 2020 – Air pollution and interstitial lung disease: a call to arms
Year: 2020


Eotaxin-3 exerts innate host defense activities that are modulated by mast cell proteases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Xylitol affects production of virulence factors and biofilm in pseudomonas aeruginosa; effects on respiratory epithelium inflammation. "In vitro" studies
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013


Dust exposure impacts haemophilus influenzae attachment and invasion of human airway epithelial cells
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016

A role for the WFDC protein, WAP2, in regulation of innate host defence in the lung
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014

Impaired neutrophil function in patients with common variable immunodeficiency (CVID)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015

Identification of viral species in asthma patients with and without aspirin hypersensitivity
Source: Annual Congress 2013 –Viral infections
Year: 2013